JPMORGAN CHASE & CO - REPARE THERAPEUTICS INC ownership

REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 72 filers reported holding REPARE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of REPARE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$98,464
+513.1%
8,151
+437.0%
0.00%
Q2 2023$16,061
+7.1%
1,518
+2.6%
0.00%
Q1 2023$15,000
+71328.6%
1,479
+2.0%
0.00%
Q4 2022$21
-100.0%
1,450
-93.8%
0.00%
Q3 2022$282,000
-9.3%
23,221
+4.7%
0.00%
Q2 2022$311,000
-12.6%
22,175
-11.4%
0.00%
Q1 2022$356,000
-29.1%
25,039
+5.3%
0.00%
Q4 2021$502,000
-33.1%
23,786
-16.7%
0.00%
Q3 2021$750,000
+1239.3%
28,554
+1496.1%
0.00%
Q2 2021$56,000
-99.0%
1,789
-99.0%
0.00%
-100.0%
Q1 2021$5,662,000
+566100.0%
184,477
+683148.1%
0.00%
Q4 2020$1,000270.00%
Other shareholders
REPARE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Versant Venture Management, LLC 2,646,657$31,971,61717.00%
MPM ASSET MANAGEMENT LLC 2,242,636$27,091,04314.51%
CHI Advisors LLC 2,966,674$35,837,42214.20%
MPM BioImpact LLC 1,639,849$19,809,3765.29%
BVF INC/IL 8,291,988$100,167,2152.70%
Deep Track Capital, LP 3,067,731$37,058,1901.43%
Redmile Group, LLC 2,404,695$29,048,7161.38%
HighVista Strategies LLC 165,173$1,995,2900.92%
Orbimed Advisors 3,322,488$40,135,6550.85%
Logos Global Management LP 500,000$6,040,0000.81%
View complete list of REPARE THERAPEUTICS INC shareholders